查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
激素替代療法市場規模、份額和趨勢分析：按產品（雌激素和黃體酮替代療法）、給藥途徑、疾病類型、地區、細分市場預測，2022-2030
市場調查報告書
商品編碼
1114019

激素替代療法市場規模、份額和趨勢分析：按產品（雌激素和黃體酮替代療法）、給藥途徑、疾病類型、地區、細分市場預測，2022-2030

Hormone Replacement Therapy Market Size, Share & Trend Analysis By Product (Estrogen & Progesterone Replacement Therapy), By Route Of Administration, By Disease Type, By Region, and Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 123 Pages | 商品交期: 2-10個工作天內

價格

激素替代療法市場增長和趨勢

根據 Grand View Research, Inc. 的一項新研究，到 2030 年，全球激素替代療法市場預計將達到 357.9 億美元。從 2022 年到 2030 年，它將以 6.4% 的複合年增長率增長。激素替代療法市場的增長主要歸因於激素疾病的流行率上升和藥物輸送系統的技術進步。根據國家罕見病組織的數據，美國大約有 70,000 人患有甲狀旁腺功能減退症。

有望將副作用降至最低並提高藥物生物利用度的技術進步將推動市場增長。增加的生物利用度增加了治療頻率。用於治療生長激素缺乏症的 NGENLA 等產品僅需每週給藥一次，這可以提高患者的依從性。此外，改進的給藥途徑有望推動產品的採用。例如，nafarelin 等鼻用雌激素製劑在女性中的依從性比傳統方法更好。

公司通過合作、夥伴關係和協議來擴大影響範圍並增加收入。例如，2021 年 9 月，默克公司與法國 BIOCORP 公司就 HGH 監測設備“Malya”的開發和銷售達成協議。它用於監控和跟蹤您的每日 HCG 治療。預計此類策略將在預測期內推動市場增長。

此外，新的激素替代療法藥物進入市場也有望成為市場增長的驅動力。例如，2021年11月，富士藥品株式會社宣布推出“F-memo（100mg膠囊）”，用於預防更年期障礙中雌激素製劑給藥期間的子宮內膜增生。 F-memo是一種口服藥物，被列入日本國民健康保險藥品價格表。這些努力可能會提高激素替代治療藥物的處方率，並成為市場增長的驅動力。

然而，嚴重的副作用是市場增長的主要製約因素。 FDA 已在雌激素治療中確定了某些藥物，這些藥物可能會導致副作用並增加女性患癌症的風險。輝瑞的 Premarin 和 Prepro 與癌症誘導有關。

激素替代療法市場亮點

按產品劃分，雌激素和孕激素替代療法細分市場預計將在 2021 年佔據市場主導地位，並在預測期內保持其主導地位，因為越來越多的女性經歷了更年期的高需求

>

由於越來越多地採用激素替代療法治療甲狀旁腺功能減退，預計甲狀旁腺激素替代療法在預測期內增長最快

從給藥途徑來看，由於處方率高，口服製劑將在 2021 年佔據市場主導地位。美國每年大約開出 1.2 億片左甲狀腺素鈉片

預計父母用藥增長最快。預計長效產品的開發和批准將推動該領域的增長。例如，2021 年 10 月，輝瑞日本公司的每週一次的長效重組人生長激素藥物 NGENLA (somatrogon) 獲得加拿大衛生部的批准，用於治療生長激素缺乏症患者。get

到 2021 年，隨著 45-60 歲年齡組中更多的女性血管舒縮症狀的發病率增加，可能導致骨質疏鬆症等嚴重疾病，預計更年期將發生。預計殘疾疾病類型細分市場將主導市場並推動市場發展成長

目錄

第1章調查方法及範圍

  • 市場細分
    • 估計/預測時間表
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 輔助信息
    • 初步調查
    • 初步調查的內容
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
      • 方法 1：商品流通方法
      • 方法 2：使用自下而上的方法估算國別市場
  • 全球市場：CAGR 計算
  • 調查假設
  • 輔助信息列表
  • 主要信息列表
  • 縮寫列表
  • 目的
    • 目的 1
    • 目的 2
    • 目標 3
    • 目標 4

第 2 章執行摘要

  • 市場概況

第 3 章市場變量、趨勢和範圍

  • 市場系列展望
    • 母公司市場展望
  • 繪製滲透率和增長前景
  • 監管和報銷框架
  • 市場變量分析
    • 市場驅動因素分析
      • 荷爾蒙失調的患病率不斷上升，接受荷爾蒙替代療法的患者人數不斷增加
      • 給藥系統技術開發
      • 加大研發投入，提高對激素缺乏症的認識
    • 市場約束分析
      • 昂貴的醫療費用
      • 副作用風險
  • 行業分析工具
    • 波特五力分析
  • 行業分析工具
    • PESTEL 分析
  • 管道分析

第 4 章激素替代療法市場 - 細分分析，按產品類型，2018-2030 年（十億美元）

  • HRT 市場：產品差異分析
  • 雌激素和孕激素替代療法
    • 2018-2030 年雌激素和孕激素替代療法市場（十億美元）
  • 人類生長激素 (HGH) 替代療法
    • 2018-2030 年 HGH 替代療法市場（十億美元）
  • 甲狀腺激素替代療法
    • 2018-2030 年甲狀腺激素替代療法市場（十億美元）
  • 睪酮替代療法
    • 2018-2030 年睪酮替代療法市場（十億美元）
  • 甲狀旁腺激素替代療法
    • 2018-2030 年甲狀旁腺激素補充劑市場（十億美元）

第 5 章激素替代療法市場 - 細分分析，按管理途徑，2018-2030 年（十億美元）

  • HRT 市場：行政路徑的變化分析
  • 口語
    • 2018-2030 年口腔市場（十億美元）
  • 腸胃外
    • 2018-2030 年育兒市場（十億美元）
  • 透皮
    • 2018-2030 年透皮市場（十億美元）
  • 其他
    • 2018-2030 年其他市場（十億美元）

第 6 章激素替代療法市場 - 細分分析，按疾病類型，2018-2030 年（十億美元）

  • HRT 市場：疾病類型的變異分析
  • 更年期
    • 2018-2030 年更年期市場（十億美元）
  • 甲狀腺功能減退
    • 2018-2030 年甲狀腺功能減退市場（十億美元）
  • 男性性腺機能減退
    • 2018-2030 年男性性腺功能減退症市場（十億美元）
  • 生長激素缺乏症
    • 2018-2030 年生長激素缺乏症市場（十億美元）
  • 甲狀旁腺功能低下
    • 2018-2030 年甲狀旁腺功能減退症（十億美元）

第 7 章激素替代療法市場 - 2018-2030 年各地區細分分析（十億美元）

  • 2021 年和 2030 年激素替代療法市場，按地區分列的市場份額
    • 北美
      • 2018-2030 年北美市場估計和預測（十億美元）
      • 美國
      • 2018-2030 年美國市場估計和預測（十億美元）
      • 加拿大
      • 2018-2030 年加拿大市場估計和預測（十億美元）
    • 歐洲
      • 2018-2030 年歐洲市場估計和預測（十億美元）
      • 英國
      • 2018-2030 年英國市場估計和預測（十億美元）
      • 德國
      • 2018-2030 年德國市場估計和預測（十億美元）
      • 法國
      • 2018-2030 年法國市場估計和預測（十億美元）
      • 西班牙
      • 2018-2030 年西班牙市場估計和預測（十億美元）
      • 意大利
      • 2018-2030 年意大利市場估計和預測（十億美元）
    • 亞太地區
      • 2018-2030 年亞太市場估計和預測（十億美元）
      • 日本
      • 2018-2030 年日本市場估計和預測（十億美元）
      • 中國
      • 2018-2030 年中國市場估計和預測（十億美元）
      • 印度
      • 2018-2030 年印度市場估計和預測（十億美元）
      • 澳大利亞
      • 2018-2030 年澳大利亞市場估計和預測（十億美元）
      • 韓國
      • 2018-2030 年韓國市場估計和預測（十億美元）
    • 拉丁美洲
      • 2018-2030 年拉丁美洲市場估計和預測（十億美元）
      • 巴西
      • 2018-2030 年巴西市場估計和預測（十億美元）
      • 墨西哥
      • 2018-2030 年墨西哥市場估計和預測（十億美元）
      • 阿根廷
      • 2018-2030 年阿根廷市場估計和預測（十億美元）
    • 中東和非洲
      • 2018-2030 年中東和非洲市場估計和預測（十億美元）
      • 南非
      • 2018-2030 年南非市場估計和預測（十億美元）
      • 沙特阿拉伯
      • 2018-2030 年沙特阿拉伯市場估計和預測（十億美元）
      • 阿拉伯聯合酋長國
      • 2018-2030 年阿拉伯聯合酋長國市場估計和預測（十億美元）

第 8 章激素替代療法市場 - 競爭分析

  • 分析重大交易和戰略聯盟
    • 推出新產品
    • 併購
    • 夥伴關係和戰略合作
    • 會議和活動
  • 公司分類
    • 市場差異化因素
    • 創新者
    • 市場領導者
  • 供應商情況
    • 主要分銷商和渠道合作夥伴列表
    • 主要客戶
  • 熱圖分析
  • 上市公司
    • 2021 年主要參與者的市場份額分析
    • 公司市場分析
  • 私人公司
    • 主要初創公司列表
    • 本地網絡地圖
  • 公司簡介
    • 拜耳公司
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 輝瑞
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 默克
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 比阿特麗斯公司
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 諾和諾德 A/S
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 禮來公司
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • F. Hoffman-La Roche（基因泰克）
      • 公司概況
      • 財務表現
      • 產品基準
    • Noven Pharmaceuticals, Inc.
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • ASCEND Therapeutics USA, LLC.（Bethan Healthcare）
      • 公司概況
      • 產品基準
      • 戰略舉措
    • 艾伯維公司
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
Product Code: 978-1-68038-784-1

Hormone Replacement Therapy Market Growth & Trends:

The global hormone replacement therapy market is expected to reach USD 35.79 billion by 2030, according to a new study by Grand View Research, Inc. expanding at a CAGR of 6.4% from 2022 to 2030. The growth in the hormone replacement therapy market is largely attributable to the rising prevalence of hormonal disorders coupled with technological advancements in drug delivery systems. According to the National Organization of Rare Diseases, there are around 70,000 people with hypoparathyroidism in the U.S.

Technological advancements to minimize the side effects and enhance drug bioavailability are expected to boost the market growth. Due to better bioavailability, the treatment frequency increases. Products such as NGENLA, which is used to treat growth hormone deficiency, require a once-a-week dosage, which ensures better patient compliance. Furthermore, improvement in the route of administration is expected to boost the adoption of products. For instance, intranasal estrogen medication such as Nafarelin is comparatively more compliant in women than the conventional method.

Companies are taking initiatives such as collaboration, partnership, and agreement to expand their business footprint and generate revenue. For instance, in September 2021, Merck & Co., Inc. entered into an agreement with BIOCORP, a French company, for the development and distribution of the HGH monitoring device, Mallya. It is used to monitor and track daily HCG treatment. Such strategies are anticipated to propel the market growth during the forecast period.

Moreover, the launch of new hormone replacement therapy medicines in the market is anticipated to drive market growth. For instance, in November 2021, Fuji Pharma Co, Ltd. announced the launch of F-meno (100 mg capsule) for the prevention of endometrial hyperplasia on the administration of estrogen drugs for menopausal disorders. F-memo is an orally administered drug and is included in Japan's National Health Insurance Drug Price list. This initiative may boost the prescription rate for hormone replacement therapy drugs, thereby driving the market growth.

However, severe adverse effects act as key restraints for market growth. The FDA has identified certain drugs in estrogen therapy that can cause adverse reactions and increase the risk of cancer in women. Premarin and Prempro, manufactured by Pfizer, are found to be associated with inducing cancer.

Hormone Replacement Therapy Market Highlights:

  • Based on the product, the estrogen & progesterone replacement therapy segment dominated the market in 2021 and is estimated to maintain its dominance during the forecast period due to high demand due to the increasing number of women reaching menopause
  • Parathyroid hormone replacement therapy is anticipated to witness the fastest growth during the forecast period due to the rising adoption of hormone replacement for the treatment of hypoparathyroidism
  • Based on the route of administration, the oral segment dominated the market in 2021 owing to the high prescription rate. Around 120 million prescriptions of Levothyroxine sodium tablets are being dispensed annually in the U.S
  • Parenteral is expected to witness the fastest growth. The development and approval of long-acting products are expected to boost segment growth. For instance, in October 2021, Pfizer, Inc. received approval for its NGENLA (somatrogon), a once-a-week long-acting recombinant human growth hormone, from Health Canada for the treatment of a patient with growth hormone deficiency
  • Menopause disease type segment dominated the market in 2021 due to the rising number of women in the age group of 45 to 60 years and increasing incidence of vasomotor symptoms that may lead to severe conditions, such as osteoporosis, which are projected to fuel market growth

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 List of Abbreviations
  • 1.12 Objectives
    • 1.12.1 Objective 1
    • 1.12.2 Objective 2
    • 1.12.3 Objective 3
    • 1.12.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Regulatory and Reimbursement Framework
  • 3.4 Market Variable Analysis
    • 3.4.1 Market driver analysis
      • 3.4.1.1 Rising prevalence of hormonal disorders and increasing number of patients undergoing hormone replacament therapy
      • 3.4.1.2 Technological developments in drug delivery systems
      • 3.4.1.3 Increasing R&D investments and rising awareness about hormone deficiency
    • 3.4.2 Market restraint analysis
      • 3.4.2.1 High cost of treatment
      • 3.4.2.2 Risk of side effects
  • 3.5 Industry Analysis Tools
    • 3.5.1 Porter's five forces analysis
  • 3.6 Industry Analysis Tools
    • 3.6.1 PESTEL Analysis
  • 3.7 Pipeline Analysis

Chapter 4 Hormone Replacement Therapy Market - Segment Analysis, by Product Type, 2018 - 2030 (USD Billion)

  • 4.1 HRT Market: Product Movement Analysis
  • 4.2 Estrogen & Progesterone Replacement Therapy
    • 4.2.1 Estrogen & Progesterone replacement therapy market, 2018 - 2030 (USD Billion)
  • 4.3 Human Growth Hormone (HGH) Replacement Therapy
    • 4.3.1 HGH replacement therapy market, 2018 - 2030 (USD Billion)
  • 4.4 Thyroid Hormone Replacement Therapy
    • 4.4.1 Thyroid hormone replacement therapy market, 2018 - 2030 (USD Billion)
  • 4.5 Testosterone Replacement Therapy
    • 4.5.1 Testosterone replacement therapy market, 2018 - 2030 (USD Billion)
  • 4.6 Parathyroid Hormone Replacement
    • 4.6.1 Parathyroid Hormone Replacement market, 2018 - 2030 (USD Billion)

Chapter 5 Hormone Replacement Therapy Market - Segment Analysis, by Route of Administration, 2018 - 2030 (USD Billion)

  • 5.1 HRT Market: Route of Administration Movement Analysis
  • 5.2 Oral
    • 5.2.1 Oral market, 2018 - 2030 (USD Billion)
  • 5.3 Parenteral
    • 5.3.1 Parenteral market, 2018 - 2030 (USD Billion)
  • 5.4 Transdermal
    • 5.4.1 Transdermal market, 2018 - 2030 (USD Billion)
  • 5.5 Others
    • 5.5.1 Others market, 2018 - 2030 (USD Billion)

Chapter 6 Hormone Replacement Therapy Market - Segment Analysis, by Disease Type, 2018 - 2030 (USD Billion)

  • 6.1 HRT Market: Disease Type Movement Analysis
  • 6.2 Menopause
    • 6.2.1 Menopause market, 2018 - 2030 (USD Billion)
  • 6.3 Hypothyroidism
    • 6.3.1 Hypothyroidism market, 2018 - 2030 (USD Billion)
  • 6.4 Male Hypogonadism
    • 6.4.1 Male Hypogonadism market, 2018 - 2030 (USD Billion)
  • 6.5 Growth Hormone Deficiency
    • 6.5.1 Growth Hormone Deficiency market, 2018 - 2030 (USD Billion)
  • 6.6 Hypoparathyroidism
    • 6.6.1 Hypoparathyroidism, 2018 - 2030 (USD Billion)

Chapter 7 Hormone Replacement Therapy Market - Segment Analysis, By Region, 2018 - 2030 (USD Billion)

  • 7.1 Hormone Replacement Therapy Market, Market Share by Region, 2021 & 2030
    • 7.1.1 North America
      • 7.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.1.2 U.S.
      • 7.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.1.3 Canada
      • 7.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.2 Europe
      • 7.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.2 UK
      • 7.1.2.2.1 UK market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.3 Germany
      • 7.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.4 France
      • 7.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.5 Spain
      • 7.1.2.5.1 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.6 Italy
      • 7.1.2.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.3 Asia-Pacific
      • 7.1.3.1 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.2 Japan
      • 7.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.3 China
      • 7.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.4 India
      • 7.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.5 Australia
      • 7.1.3.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.6 South Korea
      • 7.1.3.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.4 Latin America
      • 7.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.4.2 Brazil
      • 7.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.4.3 Mexico
      • 7.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.4.4 Argentina
      • 7.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.5 Middle East and Africa
      • 7.1.5.1 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.5.2 South Africa
      • 7.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.5.3 Saudi Arabia
      • 7.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.5.4 UAE
      • 7.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 8 Hormone Replacement Therapy Market - Competitive Analysis

  • 8.1 Major Deals and Strategic Alliances Analysis
    • 8.1.1 New Product Launch
    • 8.1.2 Mergers and Acquisitions
    • 8.1.3 Partnerships and Strategic Collaborations
    • 8.1.4 Conferences and Campaigns
  • 8.2 Company Categorization
    • 8.2.1 Market Differentiators
    • 8.2.2 Innovators
    • 8.2.3 Market Leaders
  • 8.3 Vendor Landscape
    • 8.3.1 List of key distributors and channel partners
    • 8.3.2 Key customers
  • 8.4 Heat map analysis
  • 8.5 Public Companies
    • 8.5.1 Key company market share analysis, 2021
    • 8.5.2 Company Market Position Analysis
  • 8.6 Private Companies
    • 8.6.1 List of key emerging companies
    • 8.6.2 Regional Network Map
  • 8.7 Company Profiles
    • 8.7.1 Bayer AG
      • 8.7.1.1 Company overview
      • 8.7.1.2 Financial performance
      • 8.7.1.3 Product benchmarking
      • 8.7.1.4 Strategic initiatives
    • 8.7.2 Pfizer, Inc.
      • 8.7.2.1 Company overview
      • 8.7.2.2 Financial performance
      • 8.7.2.3 Product benchmarking
      • 8.7.2.4 Strategic initiatives
    • 8.7.3 Merck & Co., Inc.
      • 8.7.3.1 Company overview
      • 8.7.3.2 Financial performance
      • 8.7.3.3 Product benchmarking
      • 8.7.3.4 Strategic initiatives
    • 8.7.4 Viatris Inc.
      • 8.7.4.1 Company overview
      • 8.7.4.2 Financial performance
      • 8.7.4.3 Product benchmarking
      • 8.7.4.4 Strategic initiatives
    • 8.7.5 Novo Nordisk A/S
      • 8.7.5.1 Company overview
      • 8.7.5.2 Financial performance
      • 8.7.5.3 Product benchmarking
      • 8.7.5.4 Strategic initiatives
    • 8.7.6 Eli Lilly and Company
      • 8.7.6.1 Company overview
      • 8.7.6.2 Financial performance
      • 8.7.6.3 Product benchmarking
      • 8.7.6.4 Strategic initiatives
    • 8.7.7 F. Hoffmann-La Roche Ltd. (Genentech)
      • 8.7.7.1 Company overview
      • 8.7.7.2 Financial performance
      • 8.7.7.3 Product benchmarking
    • 8.7.8 Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
      • 8.7.8.1 Company overview
      • 8.7.8.2 Financial performance
      • 8.7.8.3 Product benchmarking
      • 8.7.8.4 Strategic initiatives
    • 8.7.9 ASCEND Therapeutics US, LLC. (Besins Healthcare)
      • 8.7.9.1 Company overview
      • 8.7.9.2 Product benchmarking
      • 8.7.9.3 Strategic initiatives
    • 8.7.10 AbbVie Inc.
      • 8.7.10.1 Company overview
      • 8.7.10.2 Financial performance
      • 8.7.10.3 Product benchmarking
      • 8.7.10.4 Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Regulatory framework
  • Table 4 Leading market players anticipated witnessing the highest growth
  • Table 5 List of key distributors and compounding pharmacies
  • Table 6 North America hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 7 North America hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 8 North America hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 9 U.S. hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 10 U.S. hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 11 U.S. hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 12 Canada hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 13 Canada hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 14 Canada hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 15 Europe hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 16 Europe hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 17 Europe hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 18 UK hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 19 UK hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 20 UK hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 21 Germany hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 22 Germany hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 23 Germany hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 24 France hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 25 France hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 26 France hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 27 Italy hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 28 Italy hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 29 Italy hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 30 Spain hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 31 Spain hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 32 Spain hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 33 Asia Pacific hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 34 Asia Pacific hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 35 Asia Pacific hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 36 Japan hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 37 Japan hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 38 Japan hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 39 China hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 40 China hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 41 China hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 42 India hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 43 India hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 44 India hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 45 Australia hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 46 Australia hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 47 Australia hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 48 South Korea hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 49 South Korea hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 50 South Korea hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 51 Latin America hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 52 Latin America hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 53 Latin America hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 54 Brazil hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 55 Brazil hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 56 Brazil hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 57 Mexico hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 58 Mexico hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 59 Mexico hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 60 Argentina hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 61 Argentina hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 62 Argentina hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 63 Middle East & Africa hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 64 Middle East & Africa hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 65 Middle East & Africa hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 66 South Africa hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 67 South Africa hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 68 South Africa hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 59 Saudi Arabia hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 70 Saudi Arabia hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 71 Saudi Arabia hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
  • Table 72 UAE hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
  • Table 73 UAE hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 74 UAE hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Hormone Replacement Therapy Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Information Procurement
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Market Summary
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 Market Driver Impact Analysis (Current & future impact)
  • Fig. 12 Market restraint impact analysis (Current & future impact)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 HRT market product outlook: Key takeaways
  • Fig. 16 Estrogen & progesterone replacement therapy market, 2018 - 2030 (USD Million)
  • Fig. 17 HGH replacement therapy market, 2018 - 2030 (USD Million)
  • Fig. 18 Thyroid hormone replacement therapy market, 2018 - 2030 (USD Million)
  • Fig. 19 Testosterone replacement therapy market, 2018 - 2030 (USD Million)
  • Fig. 20 Parathyroid hormone market, 2018 - 2030 (USD Million)
  • Fig. 21 HRT market route of administration outlook: Key takeaways
  • Fig. 22 HRT market: Route of administration movement analysis
  • Fig. 23 Oral market, 2018 - 2030 (USD Million)
  • Fig. 24 Parenteral market, 2018 - 2030 (USD Million)
  • Fig. 25 Transdermal market, 2018 - 2030 (USD Million)
  • Fig. 26 Others market, 2018 - 2030 (USD Million)
  • Fig. 27 HRT market disease type outlook: Key takeaways
  • Fig. 28 HRT market: Disease type movement analysis
  • Fig. 29 Menopause market, 2018 - 2030 (USD Million)
  • Fig. 30 Hypothyroidism market, 2018 - 2030 (USD Million)
  • Fig. 31 Male hypogonadism market, 2018 - 2030 (USD Million)
  • Fig. 32 Growth hormone deficiency market, 2018 - 2030 (USD Million)
  • Fig. 33 Hypoparathyroidism, 2018 - 2030 (USD Million)
  • Fig. 34 HRT Regional Outlook
  • Fig. 35 Regional outlook, 2021 & 2030
  • Fig. 36 North America
  • Fig. 37 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 U.S.
  • Fig. 39 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Canada
  • Fig. 41 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Europe
  • Fig. 43 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 UK
  • Fig. 45 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Germany
  • Fig. 47 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 France
  • Fig. 49 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Spain
  • Fig. 51 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Italy
  • Fig. 53 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Asia-Pacific
  • Fig. 55 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Japan
  • Fig. 57 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 China
  • Fig. 59 China. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 India
  • Fig. 61 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Australia
  • Fig. 63 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea
  • Fig. 65 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America
  • Fig. 67 Latin America. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Brazil
  • Fig. 69 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Mexico
  • Fig. 71 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina
  • Fig. 73 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Middle East & Africa
  • Fig. 75 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 South Africa
  • Fig. 77 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Saudi Arabia
  • Fig. 79 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 UAE
  • Fig. 81 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Market differentiators
  • Fig. 83 Heat Map Analysis
  • Fig. 84 Key company market share analysis, 2021
  • Fig. 85 Company market position analysis
  • Fig. 86 Company market position analysis